x
Biosimilar Pipeline
Project Code
Therapeutic Area
Cell line & Process Development
Preclinical
Clinical
Submission
Approval
RELEUKO
Oncology Supportive Care
FYLNETRA
Oncology Supportive Care
ADL-018
Immunology & Respiratory
KSHB001
Digestive Care
KSHB002
Immunology
KSHB004
Cardiovascular
KSHB005
Anti-Diabetic (T2DM)
KSHB006
Immunology
KSHB007
Fertility Hormone
Complex Programs
505(b)(2) Pipeline
Project Code
Therapeutic Area
Early-stage development
Late-stage development
KSHN010
Oncology
KSHN007
Gaucher’s Disease
Generic Peptides Pipeline
Project Code
Therapeutic Area
Early-stage development
Late-stage development
KSHG004
Fertility Peptide
KSHN005
Fertility Peptide
KSHG006
Long acting peptide
KSHG007
Anti Diabetic (T2DM)
NCEs Pipeline
Project Code
Therapeutic Area
Proof Of Concept
Hit and Lead Identification
Lead Optimization
Candidate Selection
pre-IND & IND Enabling Studies
IND Filing
KSHN001
Oncology (Oral Candidate)
2022
KSHN001
Oncology (Injectable Candidate)
2022
KSHN002
Interstitial Cystitis
2023
KSHN016
Parkinson’s Disease
TBD
mRNA Therapy Pipeline